C
Claudio Santi
Researcher at University of Perugia
Publications - 255
Citations - 5629
Claudio Santi is an academic researcher from University of Perugia. The author has contributed to research in topics: Catalysis & Diselenide. The author has an hindex of 37, co-authored 255 publications receiving 4506 citations.
Papers
More filters
Journal ArticleDOI
Fluorine-Containing Drugs Approved by the FDA in 2018
Haibo Mei,Jianlin Han,Santos Fustero,Mercedes Medio-Simón,Daniel M. Sedgwick,Claudio Santi,Renzo Ruzziconi,Vadim A. Soloshonok,Vadim A. Soloshonok +8 more
TL;DR: The newly approved pharmaceuticals feature several types of aromatic F- and CF3-, aliphatic (CF2) substitution, offering advances in treatment of various diseases, including cancer, HIV, malarial and smallpox infections.
Journal ArticleDOI
Green Chemistry with Selenium Reagents: Development of Efficient Catalytic Reactions
TL;DR: It is shown that selenium-based catalysts can be used conveniently in a series of functional group transformations and can transfer oxygen from environmentally friendly oxidants such as H2O2.
Journal ArticleDOI
“The green side of the moon: ecofriendly aspects of organoselenium chemistry”
Stefano Santoro,Juliano B. Azeredo,Vanessa Nascimento,Luca Sancineto,Antonio L. Braga,Claudio Santi +5 more
TL;DR: The use of selenating reagents has often been limited by a generally bad reputation surrounding selenium toxicity and its potential impact on the environment as discussed by the authors, however, some aspects that will encourage the reader to discover an unexpected "green side" to this element and the chemistry connected with its organic derivatives.
Journal ArticleDOI
Design and Synthesis of DiselenoBisBenzamides (DISeBAs) as Nucleocapsid Protein 7 (NCp7) Inhibitors with anti-HIV Activity
Luca Sancineto,Alice Mariotti,Luana Bagnoli,Francesca Marini,Jenny Desantis,Nunzio Iraci,Claudio Santi,Christophe Pannecouque,Oriana Tabarrini +8 more
TL;DR: A series of 2,2'-diselenobisbenzoic scaffold, amino acid, and benzenesulfonamide derivatives are identified as novel HIV retroviral nucleocapsid protein 7 (NCp7) inhibitors and their mechanism of action is based on NCp7 inhibition.
Book
New Frontiers in Organoselenium Compounds
TL;DR: The state of the art of organoselenium compounds as reagents and catalysts for green chemistry has been discussed in this article, providing a comprehensive overview on bioactive organose-lenium compound and their potential therapeutic uses.